The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Exclusion Criteria

• •History of OA of hand surgery
• •Intra-articular injections within 3 months
• •History of OA of hand infections within 3 months
• •Who had taken a drug that has a control of result in clinical trial by investigator's decision
• •Pregnant women, nursing mothers or Fertile women who not practice contraception with appropriate methods
• •clinically significant hepatic, renal, cardiovascular diseases
• •Any history of adverse reaction to the study drugs
• •Patients with gastrointestinal ulcers or bleeding disorders
• •Finger joint injury within 6 months
• •Who had following results after examination
• •1. K ≥ 5.5mEq/L
• •2. eGFR ≤ 30ml/min/1.73m\^2
• •Patients on any other clinical trial or experimental treatment in the past 3 months
• •Taking narcotic analgesics or patches
• •History of drug abuse or alcoholism
• •Who has Galactose intolerance, LAPP lactose intolerance, glucose-galactose malabsorption or genetic disorders
• •An impossible one who participates in clinical trial by investigator's decision